Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different
ways to stop tumor cells from dividing so they stop growing or die. Interferon alfa may
interfere with the growth of tumor cells. Radiation therapy uses high-energy radiation from
x-rays and other sources to kill tumor cells. Combining chemotherapy with interferon alfa and
giving them with radiation therapy after surgery may kill any remaining tumor cells.
PURPOSE: Phase II trial to study the effectiveness of adjuvant chemoradiotherapy and
interferon alfa in treating patients who have resected stage I, stage II, or stage III
pancreatic cancer.